Cue Biopharma, Inc. SEC filings CUE
Cue Biopharma, Inc. has 552 filings in SEC EDGAR's recent list, going back to Jun 19, 2015. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Aug 12, 2026 | — |
| S-3 | Shelf registration | Jun 18, 2026 | — |
| S-8 | Employee stock plan registration | Jun 3, 2026 | — |
| S-3 | Shelf registration | Jun 3, 2026 | — |
| S-8 | Employee stock plan registration | May 1, 2026 | — |
| S-3 | Shelf registration | Mar 16, 2026 | — |
| 424B5 | Prospectus supplement | Dec 19, 2025 | — |
| 424B5 | Prospectus supplement | Dec 18, 2025 | — |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| 424B5 | Prospectus supplement | Apr 15, 2025 | — |
| 424B5 | Prospectus supplement | Apr 14, 2025 | — |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| 424B5 | Prospectus supplement | Sep 26, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| S-3 | Shelf registration | May 9, 2023 | — |
| S-8 | Employee stock plan registration | Mar 21, 2023 | — |
| 424B7 | Filing | Dec 30, 2022 | — |
| 424B3 | Prospectus | Dec 15, 2022 | — |
| S-3 | Shelf registration | Dec 6, 2022 | — |
| S-8 | Employee stock plan registration | Mar 16, 2022 | — |
| 424B5 | Prospectus supplement | Oct 1, 2021 | — |
| 424B5 | Prospectus supplement | Oct 1, 2021 | — |
| POS AM | Filing | May 21, 2021 | — |
| S-8 | Employee stock plan registration | Mar 9, 2021 | — |
| POS AM | Filing | Mar 9, 2021 | — |
| 424B5 | Prospectus supplement | Jun 22, 2020 | — |
| S-3ASR | Automatic shelf registration | Jun 22, 2020 | — |
| 424B5 | Prospectus supplement | Mar 27, 2020 | — |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| 424B5 | Prospectus supplement | Nov 25, 2019 | — |
| 424B5 | Prospectus supplement | Jun 5, 2019 | — |
| S-8 | Employee stock plan registration | Mar 14, 2019 | — |
| 424B3 | Prospectus | Feb 8, 2019 | — |
| S-3/A | Filing | Jan 14, 2019 | — |
| S-3 | Shelf registration | Jan 4, 2019 | — |
| 424B3 | Prospectus | Jul 23, 2018 | — |
| S-1/A | Amended registration statement | Jul 13, 2018 | — |
| S-1 | Registration statement | Jun 21, 2018 | — |
| S-8 | Employee stock plan registration | Mar 29, 2018 | — |
| 424B1 | Final prospectus | Dec 21, 2017 | — |
| S-1MEF | Form s-1mef | Dec 21, 2017 | — |
| S-1/A | Amended registration statement | Dec 13, 2017 | — |
| S-1/A | Amended registration statement | Dec 11, 2017 | — |
| S-1/A | Amended registration statement | Dec 5, 2017 | — |
| FWP | Free writing prospectus | Dec 5, 2017 | — |
| S-1/A | Amended registration statement | Nov 17, 2017 | — |
| S-1/A | Amended registration statement | Nov 2, 2017 | — |
| S-1 | Registration statement | Sep 21, 2017 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CUE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Somerville, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1645460
- Former names
- Imagen Biopharma, Inc. (until Jun 19, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.